Data completeness
5/8 — Partial
CORTEF (hydrocortisone) by Pfizer is clinical pharmacology glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Approved for dermatomyositis, temporal arteritis, polymyositis and 14 more indications.
Drug data last refreshed 19h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CORTEF (hydrocortisone) is a naturally occurring glucocorticoid administered via injection for rapid anti-inflammatory and immunomodulatory effects. It treats autoimmune, allergic, and hematologic disorders including lupus, rheumatoid arthritis, asthma, and leukemia by suppressing immune response and reducing inflammation across multiple organ systems.
$0.683MPart D
LOE ApproachingDeclining
Product is approaching loss of exclusivity with minimal Part D utilization, indicating a contracting market with reduced commercial team investment.
Mechanism of Action
CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement…
Indications (17)
Worked on CORTEF at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.